Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07725601) titled 'VNS Algorithm for Advanced Dosing' on July 21.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Fernando Vale

Condition: Epilepsies

Intervention: Device: Rapid Titration VNS programming

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: August 1, 2025

Target Sample Size: 80

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07725601

Published by HT Digital Content Services with permission from Health Daily Di...